The Discounted Cash Flow (DCF) valuation of Dallah Healthcare Company SJSC (4004.SR) is 67.98 SAR. With the latest stock price at 128.10 SAR, the upside of Dallah Healthcare Company SJSC based on DCF is -46.9%.
Based on the latest price of 128.10 SAR and our DCF valuation, Dallah Healthcare Company SJSC (4004.SR) is a sell. selling 4004.SR stocks now will result in a potential gain of 46.9%.
| Range | Selected | |
| WACC / Discount Rate | 11.2% - 13.7% | 12.5% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 53.07 - 92.22 | 67.98 |
| Upside | -58.6% - -28.0% | -46.9% |